intracellular biologics (Elasmogen/Feldan Therapeutics/Amgen)
N/A
Report date: 2025/06/11 10:52:35
Base Information
Drug Nameintracellular biologics (Elasmogen/Feldan Therapeutics/Amgen)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElasmogen Ltd
China Registration ClassN/A
Develop Information
Active CompaniesFeldan TherapeuticsAmgen IncElasmogen Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A